BEGIN:VCALENDAR
PRODID:-//Pixl8//Eventfolio//EN
VERSION:2.0
X-WR-TIMEZONE:Europe/London
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:Europe/London
LAST-MODIFIED:20260721T092906Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
TZNAME:BST
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:GMT
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261020T160000
DTEND;TZID=Europe/London:20261020T170000
DTSTAMP:20260929T051114Z
UID:{9A7247E4-4A98-454B-A4A25959235FCDBC}
LOCATION:
SUMMARY:BioInnovate Webinar: Scaling for Success: Establishing AAV Processes that Deliver
DESCRIPTION:By attending this webinar, you will learn:\n
 \n
 •	Insights into Touchlight’s cell-free DNA platform, including R&D and GMP manufacturing capabilities, and experience in supporting advanced therapy clinical programmes.\n
 •	How Doggybone DNA (dbDNA™) can increase AAV genome titres, improve full capsid percentages, and reduce impurity packaging.\n
 •	How Pharmaron’s scalable AAV platform enables seamless progression from early feasibility studies through manufacturing.\n
 •	The value of leveraging small-scale upstream models to accelerate process development while maintaining scalability.\n
 •	How collaboration with innovators and technology providers helps drive continuous platform evolution.\n
 •	A case study highlighting the impact of this collaborative, innovation-driven approach on AAV process development.\n
 \n
 Event details: https://www.bioindustry.org/events/our-events/bioinnovate-webinar-scaling-for-success-establishing-aav-processes-that-deliver.html
PRIORITY:1
END:VEVENT
END:VCALENDAR